ALLO Key Financial Ratios - Allogene Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	10.72	—	-30.08%	-37.94%
2026-03-31	9.65	—	-43.88%	-62.31%
2025-12-31	7.93	—	-45.90%	-65.25%
2025-09-30	8.19	—	-48.21%	-67.24%
2025-06-30	8.92	—	-50.34%	-68.76%
2025-03-31	9.71	—	-49.67%	-65.47%
2024-12-31	8.54	—	-46.94%	-61.01%
2024-09-30	9.35	—	-48.11%	-61.12%
2024-06-30	12.25	—	-43.20%	-54.25%
2024-03-31	12.8	—	-49.85%	-63.35%
2023-12-31	12.38	—	-50.91%	-63.89%
2023-09-30	12.63	—	-47.48%	-58.34%
2023-06-30	9.2	—	-46.52%	-57.87%
2023-03-31	8.11	—	-47.35%	-60.00%
2022-12-31	9.84	—	-40.78%	-50.24%
2022-09-30	11.84	—	-26.57%	-31.97%
2022-06-30	11.61	—	-24.35%	-28.86%
2022-03-31	12.83	—	-23.40%	-26.45%
2021-12-31	9.78	—	-17.53%	-19.68%
2021-09-30	9.4	—	-23.23%	-25.85%
2021-06-30	13.09	—	-21.19%	-23.32%
2021-03-31	13.06	—	-19.40%	-21.38%
2020-12-31	8.96	—	-20.38%	-24.69%
2020-09-30	17.04	—	-19.85%	-21.69%
2020-06-30	22.24	—	-18.05%	-19.53%
2020-03-31	18.81	—	-30.14%	-34.21%
2019-12-31	16.46	—	-25.72%	-29.35%
2019-09-30	15.28	—	-22.15%	-24.86%
2019-06-30	13.46	—	-20.00%	-22.40%
2019-03-31	17.48	—	-32.09%	-35.30%
2018-12-31	15.89	—	-27.33%	-30.08%
2018-09-30	1.55	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	7.93	—	-45.90%	-65.25%
2024-12-31	8.54	—	-46.94%	-61.01%
2023-12-31	12.38	—	-50.91%	-63.89%
2023-09-30	12.63	—	—	—
2023-06-30	9.2	—	—	—
2023-03-31	8.11	—	—	—
2022-12-31	9.84	—	-41.43%	-51.05%
2022-09-30	11.84	—	—	—
2022-06-30	11.61	—	—	—
2022-03-31	12.83	—	—	—
2021-12-31	9.78	—	-17.53%	-19.68%
2020-12-31	8.96	—	-20.38%	-24.69%
2019-12-31	16.46	—	-25.72%	-29.35%
2018-12-31	15.89	—	-27.33%	-30.08%